Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
disease | 0.100 | None | 0.976 | 42 | 0 | 1994 | 2019 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
disease | 0.100 | None | 0.927 | 41 | 1 | 1994 | 2019 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.100 | None | 0.947 | 38 | 0 | 1994 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.100 | None | 0.781 | 32 | 1 | 1994 | 2018 | ||||||||
|
DCC netrin 1 receptor | 0.471 | 0.808 | 0.99 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1994 | 1999 | ||||||||
|
kallikrein related peptidase 3 | 0.443 | 0.885 | 4.4E-06 |
|
disease | 0.100 | None | 1.000 | 37 | 0 | 1995 | 2020 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.100 | None | 1.000 | 30 | 1 | 1995 | 2019 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.963 | 27 | 2 | 1995 | 2020 | ||||||||
|
mucin 1, cell surface associated | 0.384 | 0.885 | 1.9E-02 |
|
disease | 0.100 | None | 0.917 | 24 | 0 | 1995 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.100 | None | 1.000 | 17 | 0 | 1995 | 2020 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 1995 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.090 | None | 0.778 | 9 | 0 | 1995 | 2017 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1995 | 2015 | ||||||||
|
TBC1 domain family member 9 | 0.399 | 0.846 | 2.8E-05 |
|
disease | 0.060 | None | 0.667 | 6 | 0 | 1995 | 2012 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 1995 | 2017 | ||||||||
|
fibroblast growth factor 4 | 0.588 | 0.577 | 0.14 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2018 | ||||||||
|
CD9 molecule | 0.528 | 0.769 | 4.7E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2007 | ||||||||
|
immunoglobulin heavy variable 1-12 (pseudogene) | 0.569 | 0.654 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | |||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.100 | None | 0.982 | 57 | 0 | 1996 | 2020 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
disease | 0.100 | None | 0.944 | 18 | 0 | 1996 | 2019 | ||||||||
|
CD82 molecule | 0.507 | 0.731 | 1.3E-08 |
|
disease | 0.100 | None | 0.938 | 16 | 0 | 1996 | 2019 | ||||||||
|
TIMP metallopeptidase inhibitor 1 | 0.380 | 0.885 | 0.50 |
|
disease | 0.100 | None | 0.923 | 13 | 0 | 1996 | 2019 | ||||||||
|
thymidine phosphorylase | 0.495 | 0.769 | 1.2E-04 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 1996 | 2018 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 1996 | 2016 | ||||||||
|
synthesis of cytochrome C oxidase 2 | 0.479 | 0.846 | 7.5E-07 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 1996 | 2018 |